Sunnyvale, CA & Helsinki – Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in [...]

CAMBRIDGE, MASSACHUSETTS –— IMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone payments through 2015. Upon completion of the acquisition, Illumina [...]

Agilent Technologies Inc. (NYSE: A) today introduced OpenLAB Data Store with Lab Applications, an out-of-the-box solution for smaller laboratories that provides secure central storage of the data produced by Agilent's OpenLAB chromatography data systems. The software is also designed to streamline the management of laboratory operations, assets and regulatory compliance. Other commercially available solutions are [...]

BOSTON and SAN DIEGO —— Partners HealthCare and Illumina, Inc. (NASDAQ:ILMN) today announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare, and Illumina. The members represent a diverse and distinguished group of laboratories within leading academic institutions and commercial organizations who are [...]

Almac and TTP Labtech announced today the formation of an alliance in the field of fluorescence lifetime (FLT) technology to provide class leading screening performance. This will give customers of either party access to a broad range of biological applications coupled with the next generation of microplate reader technology. FLT as a reading modality offers [...]

Hilden, Germany, and Germantown, Maryland,— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced three separate agreements that add multiple biomarkers to QIAGEN’s deep development pipeline of diagnostics for Personalized Healthcare applications to guide treatments with various medicines based on a patient’s genomic information. QIAGEN intends to develop new diagnostics to guide treatment decisions [...]

Mülheim an der Ruhr/Germany,-- the Schauenburg International Group has acquired the majority of the shares of the Markes International Group, headquartered in Llantrisant, United Kingdom. Markes develops and manufactures leading-edge technology for analyzing trace organic chemicals by gas chromatography. The company is world leader in analytical thermal desorption technology, and its ALMSCO division supplies groundbreaking [...]

San Dimas, CA – CRAIC Technologies is a leading innovator in the field of optical microanalysis. CRAIC Technologies is proud to introduce the new state-of-the-art in Raman microspectroscopy: the CRAIC Artemis™ Raman microspectrometer. D esigned to be added to many different types of optical microscopes, the CRAIC Artemis™ offers very high sensitivity, high resolution, a [...]

TORONTO, - Effective January 10, 2013 Carl Zeiss Canada is pleased to announce a new exclusive agreement with Inter Medico to distribute its clinical microscopy product line across Canada. This new partnership will significantly extend Zeiss's reach into the hospital markets and clinical accounts which focus on patient health care and diagnosis. "Although our growth [...]